Newsoara Biopharma Co., Ltd.

This early-stage study is testing a new drug, HY8931, in 60 healthy adults aged 18 to 45. The main goal is to see if the drug is safe and how the body processes it. Participants will receive either the drug or a placebo and be monitored for up to 90 days.

This early-stage study is testing a new drug, HY6725, in 74 healthy adults aged 18 to 55. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo as a single shot or multiple shots, and are followed for up to …